TIFFANY GERBER: Open Payments
NPI 1891361440 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,664 in 132 payments from 17 companies in 2025. Trend: 2023 $1,837 · 2024 $2,833 · 2025 $2,664
Food & beverage: $2,517Education: $146
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 25 | $552 |
| ABBVIE INC. | 17 | $429 |
| Regeneron Healthcare Solutions, Inc. | 11 | $416 |
| UCB, Inc. | 31 | $321 |
| GENZYME CORPORATION | 9 | $239 |
| Novartis Pharmaceuticals Corporation | 7 | $155 |
| PFIZER INC. | 7 | $107 |
| Incyte Corporation | 5 | $91 |
| Organogenesis Inc. | 5 | $86 |
| E.R. Squibb & Sons, L.L.C. | 3 | $53 |
Products named: DUPIXENT, TREMFYA, Bimzelx, SKYRIZI, RINVOQ, CIBINQO, OPZELURA, Sotyktu.
Industry payments across AL — which companies pay providers there.
